A detailed history of Pathstone Holdings, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 13,450 shares of BIIB stock, worth $2.34 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
13,450
Previous 11,690 15.06%
Holding current value
$2.34 Million
Previous $2.52 Million 23.69%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$190.52 - $236.72 $335,315 - $416,627
1,760 Added 15.06%
13,450 $3.12 Million
Q1 2024

May 13, 2024

BUY
$212.02 - $267.71 $271,597 - $342,936
1,281 Added 12.31%
11,690 $2.52 Million
Q4 2023

Feb 14, 2024

BUY
$222.59 - $267.94 $2.32 Million - $2.79 Million
10,409 New
10,409 $2.69 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.